GlycoMimetics GLYC 深 沪
等待开盘 08-25 09:30:00 美东时间
0.157
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.157
- 总市值 1.01万
- 52周最高 63.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 14.06
- 委 比 0.00%
- 总股本 6.45万
- 历史最高 2605.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 14.06
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Geron Announces Appointment of New Members to its Board of Directors
Geron Corporation announced the appointment of Patricia S. Andrews and Constantine Chinoporos to its Board of Directors. Both bring extensive experience in the biopharmaceutical industry, particularly in commercial-stage organizations. Their expertise will support Geron's strategic priorities and the commercial growth of RYTELO<sup>®</sup>, a treatment for lower-risk myelodysplastic syndromes/neoplasms (LR-MDS). Andrews and Chinoporos have held s...
03-26 12:00
Crescent Biopharma Completes Merger with GlycoMimetics
GlycoMimetics ( ($GLYC) ) has provided an announcement. On June 16, 2025, Cresc...
2025-06-19 05:49
GlycoMimetics shares are trading higher after the company approved the proposed merger with Crescent Biopharma and announced a 1-for-100 reverse stick split.
GlycoMimetics shares are trading higher after the company approved the proposed...
2025-06-06 04:04
GlycoMimetics Announces Merger Amidst Uncertainties
GlycoMimetics ( ($GLYC) ) has provided an announcement. GlycoMimetics has annou...
2025-05-30 20:58
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares increased by 98.3% to $4.6...
2025-04-23 20:06
Cantor Fitzgerald Initiates Coverage On GlycoMimetics with Overweight Rating
Cantor Fitzgerald analyst Eric Schmidt initiates coverage on GlycoMimetics (NASDAQ:GLYC) with a Overweight rating.
2025-03-21 22:12
